共 54 条
[11]
Okamoto H(2007)Phase II study of amrubicin in previously untreated patients with extensive-disease small cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) study Investig New Drugs 25 253-258
[12]
Watanabe K(2006)A phase I study of amrubicin combined with carboplatin for elderly patients with small-cell lung cancer J Thorac Oncol 1 551-555
[13]
Kunikane H(2006)Amrubicin for treatment of refractory or relapsed small-cell lung cancer: a phase II thoracic oncology research group study 0301 J Clin Oncol 24 5448-5453
[14]
Ishizumi K(2007)Evaluation of the recommended dose and efficacy of amrubicin as second- and third-line chemotherapy for small cell lung cancer J Thorac Oncol 2 741-744
[15]
Hanada M(2006)Phase II trial of amrubicin in patients with previously treated small cell lung cancer (SCLC) Proc Am Soc Clin Oncol 24 abst-155
[16]
Yamaoka T(1995)Oral etoposide and carboplatin. Effective therapy for elderly patients with small cell lung cancer Am J Clin Oncol 18 149-962
[17]
Hanada M(2001)Etoposide phosphate with carboplatin in the treatment of elderly patients with small-cell lung cancer: a phase II study Ann Oncol 12 957-158
[18]
Ichii S(2006)Multicenter phase II study of amrubicin, 9-amino-anthracycline, in patients with advanced non-small-cell lung cancer (Study 1): West Japan Thoracic Oncology Group (WJTOG) trial Investig New Drugs 24 151-undefined
[19]
Morisada S(undefined)undefined undefined undefined undefined-undefined
[20]
Yanagi Y(undefined)undefined undefined undefined undefined-undefined